The new RSV vaccines for older adults - Mayo Clinic Press
Sep 19, 2023 · In May 2023, pharmaceutical companies GSK and Pfizer received approval from the U.S. Food and Drug Administration (FDA) for their RSV vaccines within weeks of each other. Both vaccines are currently available. Here’s what you need to know about RSV and the two new vaccines designed to protect against it.
CDC Updates RSV Vaccination Recommendation for Adults
Jun 26, 2024 · Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine.
FDA approves Pfizer's RSV vaccine for adults at increased risk of …
Oct 22, 2024 · The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of...
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults …
Oct 22, 2024 · ABRYSVO now offers the broadest RSV vaccine indication for adults, which previously included those 60 years and older. Additionally, it remains the only RSV immunization approved for pregnant individuals at 32 through 36 weeks of gestation to protect infants from birth up to 6 months of age.
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
RSV Vaccine Guidance for Older Adults | RSV | CDC
Aug 30, 2024 · CDC recommends a single dose of RSV vaccine for older adults to help prevent serious RSV infection and hospitalization. RSV vaccination is recommended for the following adults: All adults ages 75 and older. Adults ages 60–74 at increased risk of severe RSV disease.
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · The US Food and Drug Administration approved the first vaccine against respiratory syncytial virus, known as RSV, and vaccines are in the works.
Federal Officials Revise Recommendations for R.S.V. Vaccine
Jun 26, 2024 · The Centers for Disease Control and Prevention recommended last year that adults age 60 or older could receive a single lifetime dose of an R.S.V. vaccine, in consultation with their health...
FDA approves Moderna’s mRNA RSV vaccine for older adults
May 31, 2024 · The US Food and Drug Administration has approved another vaccine that can help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the name...
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older …
Dec 13, 2023 · Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F...
- Some results have been removed